Elan Corporation, Plc
Web: http://www.elan.com
E-Mail:
Address: 800 Gateway Boulevard, South San Francisco, California 94080, USA
Phone: +001-(650)-877 0900 | Fax: +001-(650)-877 7669 | Map/Directions >>
Profile: Elan Corporation, Plc is a neuroscience-based biotechnology company which focuses on discovering, developing, manufacturing & marketing advanced therapies in neurology, autoimmune diseases & severe pain. Our Tysabri®, formerly referred to as antegren, is a treatment for relapsing forms of multiple sclerosis to reduce the frequency of clinical relapses. Our PRIALT® is used for the management of severe chronic pain in patients for whom intrathecal therapy is warranted. Our Azactam® (aztreonam injection) contains the active ingredient aztreonam, a monobactam. It was originally isolated from Chromobacterium violaceum. It is a synthetic bactericidal antibiotic. It is indicated for the treatment of infections caused by susceptible gram-negative microorganisms.
The company has revenues of USD 500 Million to 1 Billion, has ~1690 employees. NYSE:ELN (SEC Filings)
14 Products/Services (Click for related suppliers)
|
| • Blood Analyzer Reagents |
| • Chemistry Analyzers |
| • Clinical Immunochemistry Analyzers |
| • Controls for Diagnostic Equipment |
| • General Medical Supplies |
| • Hypnotics & Sedatives |
| • Immuno Chemistry Analyzers |
| • Immunoassay Equipment, Immunochemistry Analyzers |
| • Miscellaneous Injectables |
| • Nasal Inhaler (FDA Code: KCO / 874.5220) An ear, nose, and throat drug administration device is one of a group of ear, nose, and throat devices intended specifically to administer medicinal substances to treat ear, nose, and throat disorders. These instruments include the powder blower, dropper, ear wick, manual nebulizer pump, and nasal inhaler. |
| • Nervous System |
| • Pharmaceuticals/Chemicals Contract Manufacturing |
| • Seizure Suppressants |
| • Unit-Dose Drug Delivery System |
